Navigation Links
Adalimumab may reduce health-care costs for Crohn's disease patients
Date:11/12/2008

t to examine the effect of adalimumab maintenance treatment on both all-cause and CD-related hospitalizations. Of the 778 patients randomized, 260 were assigned to adalimumab every other week, 257 were assigned to adalimumab weekly and 261 received placebo.

Both three- and 12-month hospitalization risks were significantly lower for patients who received adalimumab. In addition, adalimumab every other week and weekly maintenance therapies were associated with 52 percent and 60 percent relative reductions in 12-month, all-cause hospitalization risk, and 48 percent and 64 percent reductions in 12-month risk of CD-related hospitalization.

The combined adalimumab group was associated with 56 percent reductions in both all-cause and CD-related hospitalization risks. Fewer CD-related surgeries occurred in the adalimumab every other week, weekly and combined groups compared with placebo (0.4, 0.8 and 0.6 versus 3.8 per 100 patients, all p<0.05).

"It is important to recognize that CD patients experience comorbidities such as osteoporosis, depression and anxiety disorders, which may improve following successful medical management," said Brian G. Feagan, MD, of the University of Western Ontario and lead author of the study. "Accordingly, the significant decrease in all-cause hospitalization we observed following adalimumab maintenance treatment suggests that therapy may reduce total health-care costs incurred by CD patients. Decreasing the incidence of hospitalization and surgery may be the key to controlling the total health-care burden of CD."

CD is a chronic inflammatory bowel disease that primary affects the small intestine and colon. Because it frequently occurs earlier in life than many other chronic conditions, it imposes a substantial burden. There is remarkable consistency in the literature that hospitalization costs, including surgery, make up 56 percent to 63 percent of the total direct costs. In addition, other economic studies
'/>"/>

Contact: Alissa Cruz
media@gastro.org
301-272-1603
American Gastroenterological Association
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
2. HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity
3. Data Show that Abbotts HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
4. Adalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapies
5. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
6. Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
7. Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)
8. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
9. Dual treatment for stroke leads to improved recovery rates, reduced mortality
10. Calcium plus vitamin D supplementation is not associated with a reduced breast cancer risk
11. Study: Smoking Ban Would Help Reduce Heart Attack Admissions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... As the Ebola outbreak in Liberia worsens, ... both purchase critical emergency supplies locally, as well as ship ... supplies will contain materials used to control the spread of ... of the country. , With a large programmatic presence ... the Ebola outbreak in the region. The current epidemic remains ...
(Date:7/29/2014)... 29, 2014 Many people complain about their ... do each morning is put on glasses to see their ... same individuals also may be dissatisfied with their vision even ... Cataracts may cause difficulty driving, especially at night due to ... find one’s golf ball, see the TV, sew or cross ...
(Date:7/29/2014)... Thompson HealthDay Reporter , TUESDAY, ... and good sleep can protect the body against the negative ... a cellular level, researchers report. A study involving hundreds ... increased shortening of telomeres, the protective caps at the ends ... found that over a one-year period, the more stressors a ...
(Date:7/29/2014)... of living donor kidney transplants receive steady follow-up ... be monitored. To make follow-up care more accessible, ... WAG) are collaborating to launch the first program ... at no charge to living kidney donors. , ... redeemable at more than 4,500 Walgreens pharmacies and ...
(Date:7/29/2014)... Most people want to turn back the clock ... about their appearance. There are anti aging microcurrent ... that can help them to look their absolute best. ... oriented anti-aging procedures that are noninvasive and they adding some ... with cellulite. To accommodate, they are also in the ...
Breaking Medicine News(10 mins):Health News:PCI Responds to Ebola Outbreak in Liberia with Supplies, Awareness Campaigns 2Health News:PCI Responds to Ebola Outbreak in Liberia with Supplies, Awareness Campaigns 3Health News:Cataract Surgery: New Technology for Reduced Dependence on Glasses 2Health News:Healthy Habits May Slow Cellular Signs of Aging, Study Finds 2Health News:Healthy Habits May Slow Cellular Signs of Aging, Study Finds 3Health News:Caring for donors 2Health News:Caring for donors 3Health News:Supreme Skin Announces Plans for a Grand Re-opening for Their Noninvasive Anti Aging Microcurrent Face and Body Treatments In Asheville, NC 2
... 9 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. (NYSE: ... the development, manufacture and commercialization of,a broad range of ... announced financial results for the fourth quarter and fiscal ... Financial Results , Revenue in ...
... of baby boomers with eye-ailments and soaring medical ... diet supplements to protect their eyes and curb ... supplements to alleviate blinding diseases such as age-related ... growth avenues in the market.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...
... (Dublin, Ohio), the psychiatric practice of Adam Brandemihl, M.D., Board Certified ... Adult ADD. He discusses ten ways of coping with adult ADD ... ... 9, 2009 -- With the continued recession and struggling economy, keeping ...
... as the community,s new medical director. White, a Board-certified internal and ... substantial, relevant experience to Park Springs, a continuing care retirement community ... ... March 6, 2009 -- Park Springs is pleased to announce Dr. ...
... treatment provider and renowned male hormone replacement experts ... publicity concerning professional athletes within MLB testing positive ... growth hormone) may have on men suffering from ... negative image being portrayed by professional athletes -- ...
... analysis has found that certain variations in genes that ... Hodgkin disease. Published in the April 1, 2009 issue ... American Cancer Society, the study indicates that differences in ... individuals, susceptibility to this type of cancer. , Proteins ...
Cached Medicine News:Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 2Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 3Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 4Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 5Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 6Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 7Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 8Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 9Health News:Frost & Sullivan: Ageing Population and Availability of Preventative Medicines Propels Growth of European Eye Health Ingredients Market 2Health News:Frost & Sullivan: Ageing Population and Availability of Preventative Medicines Propels Growth of European Eye Health Ingredients Market 3Health News:Frost & Sullivan: Ageing Population and Availability of Preventative Medicines Propels Growth of European Eye Health Ingredients Market 4Health News:Frost & Sullivan: Ageing Population and Availability of Preventative Medicines Propels Growth of European Eye Health Ingredients Market 5Health News:How to Win the Battle with Adult ADD in the Workplace 2Health News:How to Win the Battle with Adult ADD in the Workplace 3Health News:Park Springs Names New Medical Director 2Health News:Park Springs Names New Medical Director 3Health News:Male Hormone Replacement Company Renewman.com Critical of MLB for Testosterone Abuse Publicity 2Health News:Male Hormone Replacement Company Renewman.com Critical of MLB for Testosterone Abuse Publicity 3Health News:Male Hormone Replacement Company Renewman.com Critical of MLB for Testosterone Abuse Publicity 4Health News:DNA differences may influence risk of Hodgkin disease 2
(Date:7/29/2014)... 29, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... two healthcare conferences during the third quarter, the 2014 ... Global Healthcare 2014 Conference.  Alexza,s corporate presentation will be ... on each event are below: , 2014 ... in Boston , MA.  The format ...
(Date:7/29/2014)... -- Edwards Lifesciences Corporation (NYSE: EW ), the ... monitoring, today reported net income for the quarter ended June ... and non-GAAP net income of $94.0 million, or $0.88 per ... earlier was $93.3 million, or $0.81 per diluted share, and ... share.  Net sales for the quarter ended ...
(Date:7/29/2014)... 29, 2014 New high priced hepatitis C ... by a projected $2.9 to $5.8 billion next year, ... Milliman released today by the Pharmaceutical Care Management Association ... increase by as much as 8.6 percent in 2015 ... Sovaldi and Olysio. The study finds that ...
Breaking Medicine Technology:Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3Edwards Lifesciences Reports Strong Second Quarter Results 2Edwards Lifesciences Reports Strong Second Quarter Results 3Edwards Lifesciences Reports Strong Second Quarter Results 4Edwards Lifesciences Reports Strong Second Quarter Results 5Edwards Lifesciences Reports Strong Second Quarter Results 6Edwards Lifesciences Reports Strong Second Quarter Results 7Edwards Lifesciences Reports Strong Second Quarter Results 8Edwards Lifesciences Reports Strong Second Quarter Results 9Edwards Lifesciences Reports Strong Second Quarter Results 10Edwards Lifesciences Reports Strong Second Quarter Results 11Edwards Lifesciences Reports Strong Second Quarter Results 12Edwards Lifesciences Reports Strong Second Quarter Results 13Edwards Lifesciences Reports Strong Second Quarter Results 14Edwards Lifesciences Reports Strong Second Quarter Results 15Edwards Lifesciences Reports Strong Second Quarter Results 16Edwards Lifesciences Reports Strong Second Quarter Results 17Edwards Lifesciences Reports Strong Second Quarter Results 18Edwards Lifesciences Reports Strong Second Quarter Results 19Edwards Lifesciences Reports Strong Second Quarter Results 20Edwards Lifesciences Reports Strong Second Quarter Results 21Edwards Lifesciences Reports Strong Second Quarter Results 22Edwards Lifesciences Reports Strong Second Quarter Results 23Edwards Lifesciences Reports Strong Second Quarter Results 24Edwards Lifesciences Reports Strong Second Quarter Results 25New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2
... GTHR.PK), announces it will soon begin offering its Real Time,PCR ... , GeneThera is set ... January of 2009. According to GeneThera Chairman, Dr. Tony ... PCR test for Johne,s disease,called HerdGuard(TM) by the first of ...
... A new cancer treatment is,realizing outstanding results against ... large, stage 4 tumor was reduced in size ... no longer could be definitely,identified on scans. Pancreatic ... diagnosis. NeoPlas Innovation,s combination of FDA-approved drugs,appears to ...
Cached Medicine Technology:GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 2GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 3GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 4New Cancer Treatment Shrinks Pancreatic Tumor 2
... The National Laboratory Training Network (NLTN) ... Association of Public Health Laboratories (APHL) and ... (CDC). NLTN provides cost-effective training in a ... resources, including a FREE Lending Library. Log ...
... The AAFP-PT Laboratory Proficiency Testing and Quality ... are designed to assist POLs, clinics and ... designed to assure accuracy of patient lab ... requirements. Participation provides the opportunity to earn ...
An indirect immunofluorescence (IFA) antibody test for the detection and semiquantitation of anti-glomerular basement membrane (GBM) antibodies in human serum. Slide Detail: 6-well Monkey Kidney Subs...
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) of IgM isotype in human serum....
Medicine Products: